Eyonis to Present Clinical Evidence for AI-Powered Lung Cancer Screening at CHEST 2026
Benoit Huet, PhD, to discuss performance of eyonis® LCS, which combines pulmonary nodule detection with malignancy assessment to aid in diagnosis Benoit Huet, PhD, to discuss performance of eyonis® LCS, which combines pulmonary nodule detection with malignancy assessment to aid in diagnosis
Read the full story on GlobeNewswire → Opens the original article on www.globenewswire.comSummary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.